Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer
Author:
Funder
AstraZeneca
Pfizer
Genentech
Taiho
Roche
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/20/6/993/473570/mdn739.pdf
Reference44 articles.
1. Optimizing endocrine therapy for breast cancer;Winer;J Clin Oncol,2005
2. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer;Buzdar;Clin Cancer Res,2001
3. Origin and characteristics of adverse events in aromatase inhibition therapy for breast cancer;Dowsett;Semin Oncol,2003
4. Challenges in the endocrine management of breast cancer;Mouridsen;Breast,2003
5. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer;Osbourne;J Natl Cancer Inst,2003
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Artemisia argyi extracts overcome lapatinib resistance via enhancing TMPRSS2 activation in HER2‐positive breast cancer;Environmental Toxicology;2024-03-06
2. Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtyping;Medicine;2023-09-22
3. A comprehensive analysis of notch signaling genes in breast cancer: Expression pattern and prognostic significance;Advances in Cancer Biology - Metastasis;2023-07
4. A comprehensive analysis of Notch signalling genes in breast cancer: Expression pattern and prognostic significance;2023-03-23
5. An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer;Current Topics in Medicinal Chemistry;2022-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3